Publications

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

Download PDF
Resource: Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

.

Related Articles

IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma

Link
Fibroblast-derived Collagen VI shapes the structure and function of the tumor-immune microenvironment in clear cell renal cell carcinoma

Link